Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue SUPPL. 1, 2009, Pages 252-258

  Cunha Neto, Edecio ^a,b   Nogueira, Luciana G ^a,b   Teixeira, Priscila C ^a,b   Ramasawmy, Rajendranath ^a,b   Drigo, Sandra A ^a   Goldberg, Anna Carla ^b   Fonseca, Simone G ^a,b   Bilate, Angelina M ^a,b   Kalil, Jorge ^a,b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b São Paulo   (Brazil)

Author keywords

Chagas disease cardiomyopathy; Chemokines; Cytokines; Energy metabolism; Gene polymorphism

Indexed keywords

EID: 68949197678     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762009000900032     Document Type: Article

References (79)

1. Abel LC, Iwai LK, Viviani W, Bilate AM, Fae KC, Ferreira RC, Goldberg AC, Juliano L, Juliano MA, Ianni B, Mady C, Gruber A, Hammer J, Sinigaglia F, Kalil J, Cunha-Neto E 2005. T cell epitope characterization in tandemly repetitive Trypanosoma cruzi B13 protein. Microbes Infect 7: 1184-1195.
2. Abel LC, Kalil J, Cunha Neto E 1997. Molecular mimicry between cardiac myosin and Trypanosoma cruzi antigen B13: identification of a B13-driven human T cell clone that recognizes cardiac myosin. Braz J Med Biol Res 30: 1305-1308.
3. Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F, Carrara D, Bocchi EA, Teixeira HC, Mady C, Kalil J, Cunha-Neto E 2001. Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun 17: 99-107.
4. Araujo FF, Gomes JA, Rocha MO, Williams-Blangero S, Pinheiro VM, Morato MJ, Correa-Oliveira R 2007. Potential role of CD4+CD25 HIGH regulatory T cells in morbidity in Chagas disease. Front Biosci 12: 2797-2806.
5. Bafica A, Santiago HC, Goldszmid R, Ropert C, Gazzinelli RT, Sher A 2006. Cutting edge: TLR9 and TLR2 signaling together account for MyD88-dependent control of parasitemia in Trypanosoma cruzi infection. J Immunol 177: 3515-3519.
6. Benvenuti LA, Roggerio A, Freitas HF, Mansur AJ, Fiorelli A, Hi-guchi ML 2008. Chronic American trypanosomiasis: parasite persistence in endomyocardial biopsies is associated with high- grade myocarditis. Ann Trop Med Parasitol 102: 481-487.
7. Beraun Y, Nieto A, Collado MD, Gonzalez A, Martin J 1998. Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas' disease. Tissue Antigens 52: 81-83.
8. Bestetti RB, Muccillo G 1997. Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol 60: 187-193.
9. Bilate AM, Cunha-Neto E 2008. Chagas disease cardiomyopathy: current concepts of an old disease. Rev Inst Med Trop São Paulo 50: 67-74.
10. Bilate AM, Salemi VM, Ramires FJ, de Brito T, Russo M, Fonseca SG, Faé KC, Martins DG, Silva AM, Mady C, Kalil J, Cunha- Neto E 2007. TNF blockade aggravates experimental chronic Chagas disease cardiomyopathy. Microbes Infect 9: 1104-1113.
11. Bilate AM, Salemi VM, Ramires FJ, de Brito T, Silva AM, Umezawa ES, Mady C, Kalil J, Cunha-Neto E 2003. The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis, Microbes Infect 5: 1116-1124.
12. Bilate AM, Teixeira PC, Ribeiro SP, Brito T, Silva AM, Russo M, Kalil J, Cunha-Neto E 2008. Distinct outcomes of Trypanosoma cruzi infection in hamsters are related to myocardial parasitism, cytokine/chemokine gene expression and protein expression profile. J Infect Dis 198: 614-623.
13. Bocchi EA 1994. Update on indications and results of the surgical treatment of heart failure. Arq Bras Cardiol 63: 523-530
14. Calzada JE, Lopez-Nevot MA, Beraun Y, Martin J 2002. No evidence for association of the inducible nitric oxide synthase promoter polymorphism with Trypanosoma cruzi infection. Tissue Antigens 59: 316-319.
15. Calzada JE, Nieto A, Beraun Y, Martin J 2001a. Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 58: 154-158.
16. Calzada JE, Nieto A, Lopez-Nevot MA, Martin J 2001b. Lack of association between NRAMP1 gene polymorphisms and Trypanosoma cruzi infection. Tissue Antigens 57: 353-357.
17. Carvajal K, Moreno-Sanchez R 2003. Heart metabolic disturbances in cardiovascular diseases. Arch Med Res 34: 89-99.
18. Colorado IA, Acquatella H, Catalioti F, Fernandez MT, Layrisse Z 2000. HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection. Hum Immunol 61: 320-325.
19. Costa GC, da Costa Rocha MO, Moreira PR, Menezes CA, Silva MR, Gollob KJ, Dutra WO 2009. Functional IL-10 gene polymorphism is associated with Chagas disease cardiomyopathy. J Infect Dis 199: 451-454.
20. Cruz-Robles D, Reyes PA, Monteon-Padilla VM, Ortiz-Muniz AR, Vargas-Alarcon G 2004. MHC class I and class II genes in Mexican patients with Chagas disease. Hum Immunol 65: 60-65.
21. Cunha-Neto E, Coelho V, Guilherme L, Fiorelli A, Stolf N, Kalil J 1996. Autoimmunity in Chagas' disease. Identification of cardiac myosin-B13 Trypanosoma cruzi protein crossreactive T cell clones in heart lesions of a chronic Chagas' cardiomyopathy patient. J Clin Invest 8: 1709-1712.
22. Cunha-Neto E, Dzau VJ, Allen PD, Stamatiou D, Benvenutti L, Higuchi ML, Koyama NS, Silva JS, Kalil J, Liew CC 2005. Cardiacgene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol 167: 305-313.
23. Cunha-Neto E, Moliterno R, Coelho V, Guilherme L, Bocchi E, Higuchi Mde L, Stolf N, Pileggi F, Steinman L, Kalil J 1994. Restricted heterogeneity of T cell receptor variable alpha chain transcripts in hearts of Chagas' disease cardiomyopathy patients. Parasite Immunol 16: 171-179.
24. Cuoco MA, Pereira AC, de Freitas HF, de Fátima Alves da Mota G, Fukushima JT, Krieger JE, Mansur AJ. 2005. Angiotensin-converting enzyme gene deletion polymorphism modulation of onset of symptoms and survival rate of patients with heart failure. Int J Cardiol 99: 97-103.
25. Deghaide NH, Dantas RO, Donadi EA 1998. HLA class I and II profiles of patients presenting with Chagas' disease. Dig Dis Sci 43: 246-252.
26. de Groof AJ, Smeets B, Groot Koerkamp MJ, Mul AN, Janssen EE, Tabak HF, Wieringa B 2001. Changes in mRNA expression profile underlie phenotypic adaptations in creatine kinase-deficient muscles. FEBS Lett 506: 73-78.
27. Drigo SA, Cunha-Neto E, Ianni B, Cardoso MR, Braga PE, Fae KC, Nunes VL, Buck P, Mady C, Kalil J, Goldberg AC 2006. TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients. Microbes Infect 8: 598-603.
28. Drigo SA, Cunha-Neto E, Ianni B, Mady C, Fae KC, Buck P, Kalil J, Goldberg AC 2007. Lack of association of tumor necrosis factor-a polymorphisms with Chagas disease in Brazilian patients. Immunol Lett 108: 109-111.
29. Fae KC, Drigo SA, Cunha-Neto E, Ianni B, Mady C, Kalil J, Goldberg AC 2000. HLA and beta-myosin heavy chain do not influence susceptibility to Chagas disease cardiomyopathy. Microbes Infect 2: 745-751.
30. Fernandez-Mestre MT, Layrisse Z, Montagnani S, Acquatella H, Catalioti F, Matos M, Balbas O, Makhatadze N, Dominguez E, Herrera F, Madrigal A 1998. Influence of the HLA class II polymorphism in chronic Chagas' disease. Parasite Immunol 20: 197-203.
31. Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, Kalil J, CunhaNeto E 2003. Increased plasma levels of tumor necrosis factor-a in asymptomatic/"indeterminate" and Chagas disease cardiomy- opathy patients. Mem Inst Oswaldo Cruz 98: 407-411.
32. Flórez O, Zafra G, Morillo C, Martín J, González CI 2006. Interleukin-1 gene cluster polymorphism in Chagas disease in a Colombian case-control study. Hum Immunol 67: 741-748.
33. Fonseca SG, Moins-Teisserenc H, Clave E, Ianni B, Nunes VL, Mady C, Iwai LK, Sette A, Sidney J, Marin ML, Goldberg AC, Guilherme L, Charron D, Toubert A, Kalil J, Cunha-Neto E 2005. Identification of multiple HLA-A*0201-restricted cruzipain and FL-160 CD8+epitopes recognized by T cells from chronically Trypanosoma cruzi-infected patients. Microbes Infect 7: 688-697.
34. Fonseca SG, Reis MM, Coelho V, Nogueira LG, Monteiro SM, Mairena EC, Bacal F, Bocchi E, Guilherme L, Zheng XX, Liew FY, Higuchi ML, Kalil J, Cunha-Neto E 2007. Locally produced survival cytokines IL-15 and IL-7 may be associated to the predominance of CD8+T cells at heart lesions of human chronic Chagas disease cardiomyopathy. Scand J Immunol 66: 362-371.
35. Garg N, Popov VL, Papaconstantinou J 2003. Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development. Biochim Biophys 1638: 106-20.
36. Gomes JA, Bahia-Oliveira LM, Rocha MO, Busek SC, Teixeira MM, Silva JS, Correia-Oliveira R 2005. Type 1 chemokine receptor expression in Chagas' disease correlates with morbidity in cardiac patients. Infect Immun 73: 7960-7966.
37. Gomes JA, Bahia-Oliveira LM, Rocha MO, Martins-Filho OA, Ga- zzinelli G, Correa-Oliveira R 2003. Evidence that development of severe cardiomyopathy in human Chagas' disease is due to a Th1-specific immune response. Infect Immun 71: 1185-1193.
38. Heddi A, Stepien G, Benke PJ, Wallace DC 1999. Coordinate induction of energy gene expression in tissues of mitochondrial disease patients. J Biol Chem 274: 22968-22976.
39. Higuchi ML, De Morais CF, Pereira Barreto AC, Lopes EA, Stolf N, Bellotti G, Pillegi F 1987. The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies. Clin Cardiol 10: 665-670.
40. Higuchi ML, Gutierrez PS, Aiello VD, Palomino S, Bocchi E, Kalil J, Bellotti G, Pileggi F 1993. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 423: 157-160.
41. Iwai LK, Juliano MA, Juliano L, Kalil J, Cunha-Neto E 2005. T-cell molecular mimicry in Chagas disease: identification and partial structural analysis of multiple cross-reactive epitopes between Trypanosoma cruzi B13 and cardiac myosin heavy chain. J Autoimmun 24: 111-117.
42. Johnston DL, Lewandowski ED 1991. Fatty acid metabolism and contractile function in the reperfused myocardium. Multinuclear NMR studies of isolated rabbit hearts. Circ Res 68: 714-725.
43. Jones EM, Colley DG, Tostes S, Lopes ER, Vnencak-Jones CL, McCurley TL 1993. Amplification of a Trypanosoma cruzi DNA sequence from inflammatory lesions in human chagasic cardiomyopathy. Am J Trop Med Hyg 48: 348-357.
44. Kalovidouris AE, Plotkin Z, Graesser D 1993. Interferon-g inhibits proliferation, differentiation and creatine kinase activity of cultured human muscle cells. II. A possible role in myositis. J Rhe matol 20: 1718-23.
45. Kolattukudy PE, Quach T, Bergese S, Breckenridge S, Hensley J, Altschuld R, Gordillo G, Klenotic S, Orosz C, Parker-Thornburg J 1998. Myocarditis induced by targeted expression of the MCP-1 gene in murine cardiac muscle. Am J Pathol 152: 101-111.
46. Kubota T, Bounoutas GS, Miyagishima M, Kadokami T, Sanders VJ, Bruton C, Robbins PD, McTiernan CF, Feldman AM 2000. Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 101: 2518-2525.
47. Layrisse Z, Fernandez MT, Montagnani S, Matos M, Balbas O, Herrera F, Colorado IA, Catalioti F, Acquatella H 2000. HLA-C(*)03 is a risk factor for cardiomyopathy in Chagas disease. Hum Immunol 61: 925-929.
48. Mady C, Cardoso RH, Barretto AC, da Luz PL, Bellotti G, Pileggi F 1994. Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 90: 3098-3102.
49. Marin-Neto JA, Cunha-Neto E, Maciel BC, Simoes MV 2007. Pathogenesis of chronic Chagas heart disease. Circulation 115: 1109-1123.
50. Marin-Neto JA, Rassi A Jr, Morillo CA, Avezum A, Connolly SJ, Sosa-Estani S, Rosas F, Yusuf S 2008. Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: the Benznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT). Am Heart J 156: 37-43.
51. Marino AP, da Silva A, dos Santos P, Pinto LM, Gazzinelli RT, Teixeira MM, Lannes-Vieira J 2004. Regulated on activation, nor-mal T cell expressed and secreted (RANTES) antagonist (Met- RANTES) controls the early phase of Trypanosoma cruzi-elicited myocarditis. Circulation 110: 1443-1449.
52. Michailowsky V, Silva NM, Rocha CD, Vieira LQ, Lannes-Vieira J, Gazzinelli RT 2001. Pivotal role of interleukin-12 and interferon- g axis in controlling tissue parasitism and inflammation in the heart and central nervous system during Trypanosoma cruzi in- fection. Am J Pathol 159: 1723-1733.
53. Milei J, Storino R, Fernandez Alonso G, Beigelman R, Vanzulli S, Ferrans VJ 1992. Endomyocardial biopsies in chronic chagasic cardiomyopathy. Immunohistochemical and ultrastructural findings. Cardiology 80: 424-437.
54. Moretti E, Basso B, Cervetta L, Brigada A, Barbieri G 2002. Patterns of cytokines and soluble cellular receptors in the sera of children with acute Chagas' disease. Clin Diagn Lab Immunol 9: 1324-1327.
55. Nieto A, Beraun Y, Collado MD, Caballero A, Alonso A, Gonzalez A, Martin J 2000. HLA haplotypes are associated with differential susceptibility to Trypanosoma cruzi infection. Tissue Antigens 55: 195-198.
56. Pascuzzo-Lima C, Mendible JC, Bonfante-Cabarcas RA 2009. Angiotensin-converting enzyme insertion/deletion gene polymorphism and progression of Chagas' cardiomyopathy. Rev Esp Cardiol 62: 320-322.
57. Pereira Barretto AC, Mady C, Arteaga-Fernandez E, Stolf N, Lopes EA, Higuchi ML, Bellotti G, Pileggi F 1986. Right ventricular endomyocardial biopsy in chronic Chagas' disease. Am Heart J 111: 307-312.
58. Ramasawmy R, Cunha-Neto E, Fae, KC, Borba SCP, Teixeira PC, Ferreira SCP, Goldberg AC, Ianni B, Mady C, Kalil J 2009. Heterozygosity for the variant S180L of the adaptor protein MAL/TIRAP in the TLR-pathway is associated with lower risk of developing chronic Chagas cardiomyopathy. J Infect, in press.
59. Ramasawmy R, Cunha-Neto E, Fae KC, Martello FG, Müller NG, Cavalcanti VL, Ianni B, Mady C, Kalil J, Goldberg AC 2006a. The monocyte chemoattractant protein-1gene polymorphism is associated with cardiomyopathy in human Chagas disease. Clin Infect Dis 43: 305-311.
60. Ramasawmy R, Cunha-Neto E, Fae KC, Muller NG, Cavalcanti VL, Drigo SA, Ianni B, Mady C, Kalil J, Goldberg AC 2006b. BAT1, a putative anti-inflammatory gene, is associated with chronic Chagas cardiomyopathy. J Infect Dis 193: 1394-1399.
61. Ramasawmy R, Fae KC, Cunha-Neto E, Borba SC, Ianni B, Mady C, Goldberg AC, Kalil J 2008. Variants in the promoter region of IKBL/NFKBIL1 gene may mark susceptibility to the development of chronic Chagas' cardiomyopathy among Trypanosoma cruzi-infected individuals. Mol Immunol 45: 283-288.
62. Ramasawmy R, Fae KC, Cunha-Neto E, Muller NG, Cavalcanti VL, Ferreira RC, Drigo SA, Ianni B, Mady C, Goldberg AC, Kalil J 2007. Polymorphisms in the gene for lymphotoxin-a predispose to chronic Chagas cardiomyopathy. J Infect Dis 196: 1836-1843.
63. Ramirez LE, Lages-Silva E, Soares-Junior JM, Chapadeiro E 1994. The hamster (Mesocricetus auratus) as experimental model in Chagas' disease: parasitological and histopathological studies in acute and chronic phases of Trypanosoma cruzi infection. Rev Soc Bras Med Trop 27: 163-169.
64. Reddy VS, Harskamp RE, van Ginkel MW, Calhoon J, Baisden CE, Kim IS, Valente AJ, Chandrasekar B 2008. Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation. J Cell Physiol 215: 697-707.
65. Reifenberg K, Lehr HA, Torzewski M, Steige G, Wiese E, Kupper I, Becker C, Ott S, Nusser P, Yamamura K, Rechtsteiner G, Warger T, Pautz A, Kleinert H, Schmidt A, Pieske B, Wenzel P, Münzel T, Löhler J 2007. Interferon-g induces chronic ac-tive myocarditis and cardiomyopathy in transgenic mice. Am J Pathol 171: 463-472.
66. Reis DD, Jones EM, Tostes S, Lopes ER, Chapadeiro E, Gazzinelli G, Colley DG, McCurley TL 1993a. Expression of major his- tocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease. Am J Trop Med Hyg 49: 192-200.
67. 4 cells and dominance of granzyme A+, CD8+ lymphocytes. Am J Trop Med Hyg 48: 637-644.
68. Reis MM, Higuchi Mde L, Benvenuti LA, Aiello VD, Gutierrez PS, Bellotti G, Pileggi F 1997. An in situ quantitative immunohistochemical study of cytokines and IL-2R+ in chronic human chagasic myocarditis: correlation with the presence of myocardial Trypanosoma cruzi antigens. Clin Immunol Immunopathol 83: 165-172.
69. Ribeirão M, Pereira-Chioccola VL, Renia L, Augusto Fragata Filho A, Schenkman S, Rodrigues MM 2000. Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans- sialidase. Parasite Immunol 22: 49-53.
70. Riol-Blanco L, Sanchez-Sanchez N, Torres A, Tejedor A, Narumiya S, Corbi AL, Sánchez-Mateos P, Rodríguez-Fernández JL 2005. The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J Immunol 174: 4070-4080.
71. Rodriguez-Perez JM, Cruz-Robles D, Hernandez-Pacheco G, Perez- Hernandez N, Murguia LE, Granados J, Reyes PA, Vargas-Alarcón G 2005. Tumor necrosis factor-a promoter polymorphism in Mexican patients with Chagas' disease. Immunol Lett 98: 97-102.
72. Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S, Matsushima K, Kaneko S 2006. Secondary lymphoid tissue chemokine (SLC/ CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci USA 103: 14098-14103.
73. Samudio M, Montenegro-James S, de Cabral M, Martinez J, Rojas de Arias A, Woroniecky O, James MA 1998. Differential expression of systemic cytokine profiles in Chagas' disease is associated with endemicity of Trypanosoma cruzi infections. Acta Trop 69: 89-97.
74. Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL, Teixeira MM 2004. Elevated concentrations of CCL2 and tumor necrosis factor-a in chagasic cardiomyopathy. Clin Infect Dis 38: 943-950.
75. Teixeira MM, Gazzinelli RT, Silva JS 2002. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 18: 262-265.
76. Vyatkina G, Bhatia V, Gerstner A, Papaconstantinou J, Garg N 2004. Impaired mitochondrial respiratory chain and bioenergetics during chagasic cardiomyopathy development. Biochim Biophys Acta 1689: 162-173.
77. Wang D, McMillin JB, Bick R, Buja LM 1996. Response of the neonatal rat cardiomyocyte in culture to energy depletion: effects of cytokines, nitric oxide and heat shock proteins. Lab Invest 75: 809-818.
78. Zafra G, Morillo C, Martin J, Gonzalez A, Gonzalez CI 2007. Polymorphism in the 3' UTR of the IL12B gene is associated with Chagas' disease cardiomyopathy. Microbes Infect 9: 1049-1052.
79. Zicker F, Smith PG, Netto JC, Oliveira RM, Zicker EM 1990. Physical activity, opportunity for reinfection and sibling history of heart disease as risk factors for Chagas' cardiopathy. Am J Trop Med Hyg 43: 498-505.